In the present study, we found that EZH2 upregulated ITGB1 transcription in breast cancer cells by functioning as a transcriptional co-factor of RNA Pol II to facilitate its binding to the ITGB1 promoter. This evidence concerns the gene EZH2 and breast carcinoma.